期刊文献+

供体特异性输血与嵌合体发生及肾移植急性排斥反应的关系 被引量:1

Relationship between chimerism and donor-specific transfusion and acute kidney transplantion rejection
下载PDF
导出
摘要 目的 :研究供体特异性输血 (DST)患者末梢血中嵌合体的发生及其与肾移植急性排斥反应的关系。方法 :肾移植患者 6 0例 ,分为 :A组 ,未行 DST的尸体肾移植 35例 (2 or 3HL A- mism atched) ;B组 ,未行 DST的活体肾移植 3例 ,HL A配型各位点无错配 ;C组 ,术前行 DST的活体肾移植 2 2例 (1 or 2 HL A- mism atched) ,利用 PCR- SSP法检测患者末梢血中的 HL A- DRB1基因。结果 :A组 1 2例 (34.3% )、B组 3例 (1 0 0 % )、C组 1 9例(86 .3% )发现了供体的 HL A- DRB1基因 ,证实有嵌合体发生。在 34例有嵌合体发生的病例中 1 4例 (4 1 .2 % )、2 6例无嵌合体存在的病例中有 1 0例 (38.5 % )发生过急性排斥反应 ,但两组间比较差异无显著性 (P>0 .0 5 ) ,同时排斥反应发生的频率、次数比较差异也无显著性 (P>0 .0 5 )。另外 ,C组病例中嵌合体现象消失 ,PCR- SSP检测转为阴性时未见排斥反应病例发生。结论 :DST有利于促进嵌合体的形成 ,嵌合体现象与急性排斥反应间无相关性 。 Objective To study the relationship between chimerism of peripheral blood and donor specific transfusion (DST) and acute kidney transplantion rejection. Methods The subjects were divided into 3 groups: group A, 35 subjects with corpse donor kidney transplantation who did not undertake DST before operation (2 or 3 HLA mismatched); group B, 3 subjects with live donor kidney transplantation who did not undertake DST before operation (none was HLA mismatched); group C, 22 subjects who undertook DST before operation (1 or 2 HLA mismatched). PCR SSP was used to check the HLA DRB1 gene in peripheral blood. Results 12 subjects (34 3%) in group A, 3 subjects (100%) group B and 19 subjects (86 3%) in group C were found donor HLA DRB1 gene. Chimerism was confirmed. 41 2% (14/34) subjects with chimerism and 38 5% (10/26) subjects without chimerism were found acute rejection,but there was no significant difference between two groups ( P >0 05), as well as the frequency and times of rejction. Moreover, chimerism disppeared in all cases in group C and there was no rejection.Conclusion DST can lengthen the survival of the donor kidney by improving the formation of micro chimerism. There is no accountable relationship between the disappearance of chimerism and acute rejection.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2004年第3期434-436,440,共4页 Journal of Jilin University:Medicine Edition
基金 国家自然科学基金资助课题 (30 2 71 2 96 ) 中国博士后基金资助 (第 30批 )
关键词 供体特异性输血 嵌合体 移植物排斥 肾移植 输血 donor-specific blood transfusion chimera graft rejection kidney transplantation blood transfusion
  • 相关文献

参考文献11

  • 1Starzl TE, Demetris AJ, Trucco M, et al. Cell migration and chimerism after whole-organ transplantation : The basis of graft acceptance [J]. Hepatology, 1992, 17: 1127-1152.
  • 2Schlitt HJ, Raddatz G, Steinhoff G, et al. Passenger lymphocytesin human liver allografts and their potential role after transplantation[J]. Transplantation, 1993,56: 951-955.
  • 3Sakurada M, Okazaki H, Sato T, et al. Peripheral blood chimerism in renal allograft recipients transfused with donorspecific blood [J]. Transplantation Proc, 1997, 29: 1187-1188.
  • 4Zhang Z, Ohkohchi N, Sakurada M, et al. Diagnosis of acute rejection by analysis of urinary DNA of donor origin in renal transplant recipients [J]. Transplantation Proc, 2001, 33:380-381.
  • 5Shapiro R, Rao AS, Fontes P, et al. Combined kidney/bone marrow transplantation-Evidence of augmentation of chimerism [J]. Transplantation, 1995, 59: 306-309.
  • 6Mc Daniel DO, Naftilan J, Hulvey K, et al. Peripheral blood chimerism in renal allograft recipients transfused with donor bone marrow [J]. Transplantation, 1994, 57: 852-856.
  • 7Alexander JW, Babcock GB, First MR, et al. The induction of immulogical hyperesponsiveness by pre-operative donorspecific transfusions and cyclosporine in human cadaveric transplants [J]. Transplantation, 1992, 53: 423-427.
  • 8Hisanaga M, Nakajima Y, Kanehiro H, et al. Clinical study on the development of allogeneic microchimerism after solid organ transplantation [J]. Jay J Transplantation, 1995, 31: 14-22.
  • 9Zhang Z, Ohkohchi N, Sakurada M, et al. Analysis of urinary DNA from origin in renal transplant recipient-new method for diagnosis of acute rejection [J]. Jay J Transplantation, 2000,36: 1-8.
  • 10陈惠萍.肾移植病理分类-BANFF分类方案[J].肾脏病与透析肾移植杂志,1994,3(1):41-45. 被引量:9

二级参考文献1

共引文献11

同被引文献13

  • 1陈绍洋,熊利泽,杨丽芳,李扬,巩固,朱萧玲,曾毅,桑韩飞.胰肾联合移植术的麻醉及围术期管理[J].第四军医大学学报,2005,26(6):541-544. 被引量:2
  • 2Sarnak M J ,Levey A S,Schoolwerth A C,et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardio vascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention[J].Circulation, 2003, 108 (17),2154- 2169.
  • 3Kadambi P V,Javaid B. Cardiovascular disease in kidney transplant recipients: the role of anemia[J]. Adv Chronic Kidney Dis, 2004,11 (3)328- 333.
  • 4Sezer S,Ozdemir F N,Tutal E,et al. Prevalence and etiology of anemia in renal transplant recipients[J]. Transplantation Proceedings, 2006,38(2):537-540.
  • 5Chavers B M, Sullivan E K, Tejani A, et al. Pretransplant blood transfusion and renal allograft outcome:a report of the North American pediatric renal transplantation cooperative study[J]. Pedi atr Transplant,1997,1(1) :22- 28.
  • 6Hardy S, Lee S H, Terasaki P I, et al. Sensitization 2001[J]. Clin Transplantation, 2001 : 271 -278.
  • 7Soosay A,O' Neill D, Counihan A, et al. Causes of sensitization in patients awaiting renal transplantation in Ireland[J]. Ir Med J, 2003,96(4):109 -112.
  • 8Aguilera A, Bajo M A, Diez J J, et al. Effects of human recombinant erythropoietin on inflammatory status in peritoneal dialysis patients [J]. Adv Perit Dial, 2002,18 : 200- 205.
  • 9Lietz K,Lao M,Paczek L,et al. The impact of pretransplant eryth- ropoietin therapy on late outcomes of renal transplantation[J].Ann Transplant,2003,8(2) : 17-24.
  • 10Baron F,Frere P,Fillet G,et al. Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood stem cell transplant when started soon after engraftment[J]. Clin Cancer Res,2003, 9(15) :5566-5572.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部